Chapter 3
Chapter 4
Chapter 5
Chapter 5
100

This type of law allows companies to receive tax advantages if they develop drugs that are designed to treat rare diseases and hence are not very profitable.

Orphan Drug Law

100

This term is described as the maintenance of internal stability

Homeostasis

100

This term is described as the difference between the dose of drug necessary to cause a therapeutic effect versus the dose necessary to cause a toxic effect.

Margin of safety

100

Metabolism can do these three things 

Inactivates drugs, helps to eliminate drugs more rapidly, and inactivate hormones and neurotransmitters

200

Drugs under this schedule have high abuse potential but are approved for medical purposes.

Schedule II

200

This hormone is not a neurotransmitter?

Androgen

200

The capacity of a drug to do damage or cause adverse effects in the body is know as (hint-ends in ty)

Toxicity

200

This term refers to changes that decrease response to a set dose of a drug.

Tolerance

300

This Act allowed the manufacturer to determine whether a drug was to be labeled prescription or nonprescription.

Food, Drug, and Cosmetic Act of 1938

300

Sedation and a mellowing of temper is an unlikely side effect of abusing this type of drug.

Anabolic steroids

300

This term is described as the ability of one drug to enhance the effect of another.

Synergism

300

A comparison of dosage for therapeutic versus toxic effects is the best description of this concept 

Margin of safety

400

Neurons are responsible for conducting the homeostatic functions of this body organ.

Brain

400

The principal forms of drug administration include these three forms

Injection, oral ingestion, and inhalation

400

This type of interaction is described as the kind of drug effect that occurs when one drug cancels or blocks the effect of another.

Interceptive interaction

500

Drugs that are very fat soluble are most likely to affect this body organ

Brain

500

This type of effect is described as the maximum drug effect, regardless of dose

Plateau effect

M
e
n
u